Cargando…

Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

PURPOSE: To assess the efficacy and exploratory biomarkers of continuing palbociclib plus endocrine therapy (ET) beyond progression on prior palbociclib-based regimen in patients with hormone receptor–positive/HER2-negative (HR(+)/HER2(−)) advanced breast cancer (ABC). PATIENTS AND METHODS: The mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albanell, Joan, Pérez-García, José Manuel, Gil-Gil, Miguel, Curigliano, Giuseppe, Ruíz-Borrego, Manuel, Comerma, Laura, Gibert, Joan, Bellet, Meritxell, Bermejo, Begoña, Calvo, Lourdes, de la Haba, Juan, Espinosa, Enrique, Minisini, Alessandro Marco, Quiroga, Vanesa, Santaballa Bertran, Ana, Mina, Leonardo, Bellosillo, Beatriz, Rojo, Federico, Menéndez, Silvia, Sampayo-Cordero, Miguel, Popa, Crina, Malfettone, Andrea, Cortés, Javier, Llombart-Cussac, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Clinical Trials: Targeted Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811162/ https://www.ncbi.nlm.nih.gov/pubmed/36165912 http://dx.doi.org/10.1158/1078-0432.CCR-22-1281

Ejemplares similares

Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial
por: Di Cosimo, Serena, et al.
Publicado: (2022)

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
por: Gion, María, et al.
Publicado: (2021)

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2020)

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2021)

Nobody dares stopping clinical research, not even COVID-19
por: Malfettone, Andrea, et al.
Publicado: (2021)

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2023)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Indirect Decompression Failure After Lateral Lumbar Interbody Fusion—Reported Failures and Predictive Factors: Systematic Review
por: Kirnaz, Sertac, et al.
Publicado: (2020)

The role of CDK4/6 inhibitors in early breast cancer
por: Gil-Gil, Miguel, et al.
Publicado: (2021)

Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2019)

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial
por: Pérez-García, José Manuel, et al.
Publicado: (2022)

Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study
por: Sánchez-Conde, Matilde, et al.
Publicado: (2022)

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2020)

Overall Survival with Palbociclib and Fulvestrant in Women with HR(+)/HER2(−) ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
por: Cristofanilli, Massimo, et al.
Publicado: (2022)

Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B
por: Clark, Amy S., et al.
Publicado: (2023)

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial
por: López-Miranda, Elena, et al.
Publicado: (2020)

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial
por: Tibau, Ariadna, et al.
Publicado: (2023)

Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer
por: Sorah, Jonathan D, et al.
Publicado: (2022)

Lysosomal trapping of palbociclib and its functional implications
por: Llanos, Susana, et al.
Publicado: (2019)

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
por: Lassman, Andrew B., et al.
Publicado: (2022)

Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
por: Bellet, Meritxell, et al.
Publicado: (2019)

Mind Perception Is the Essence of Morality
por: Gray, Kurt, et al.
Publicado: (2012)

Neuroethics: A New Way of Doing Ethics
por: Levy, Neil
Publicado: (2011)

A Life Worth Giving? The Threshold for Permissible Withdrawal of Life Support From Disabled Newborn Infants
por: Wilkinson, Dominic James
Publicado: (2011)

Just How Cognitive Is “Cognitive Enhancement”? On the Significance of Emotions in University Students' Experiences with Study Drugs
por: Vrecko, Scott
Publicado: (2013)

Troubled sleep: Night waking, breastfeeding and parent–offspring conflict
por: Haig, David
Publicado: (2014)

Thinking Ahead on Deep Brain Stimulation: An Analysis of the Ethical Implications of a Developing Technology
por: Johansson, Veronica, et al.
Publicado: (2014)

Brave New Love: The Threat of High-Tech “Conversion” Therapy and the Bio-Oppression of Sexual Minorities
por: Earp, Brian D., et al.
Publicado: (2014)

Patient and Citizen Participation in Health: The Need for Improved Ethical Support
por: Williamson, Laura
Publicado: (2014)

Ethics of Clinical Science in a Public Health Emergency: Drug Discovery at the Bedside
por: Edwards, Sarah J. L.
Publicado: (2013)

Treating Patients as Persons: A Capabilities Approach to Support Delivery of Person-Centered Care
por: Entwistle, Vikki A., et al.
Publicado: (2013)

The Use of Deception in Public Health Behavioral Intervention Trials: A Case Study of Three Online Alcohol Trials
por: McCambridge, Jim, et al.
Publicado: (2013)

If I Could Just Stop Loving You: Anti-Love Biotechnology and the Ethics of a Chemical Breakup
por: Earp, Brian D., et al.
Publicado: (2013)

A Threat to Autonomy? The Intrusion of Predictive Brain Implants
por: Gilbert, Frederic
Publicado: (2015)

A prospective study of macrophage migration inhibitory factor as a marker of inflammatory detection
por: Zhang, Chao, et al.
Publicado: (2009)

Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework
por: Evitt, Niklaus H., et al.
Publicado: (2015)

Developmental plasticity: Bridging research in evolution and human health
por: Lea, Amanda J, et al.
Publicado: (2018)

The ER membrane protein complex is a transmembrane domain insertase
por: Guna, Alina, et al.
Publicado: (2017)

Why and how to use virtual reality to study human social interaction: The challenges of exploring a new research landscape
por: Pan, Xueni, et al.
Publicado: (2018)

Just Policy? An Ethical Analysis of Early Intervention Policy Guidance
por: Mortimer, Rose, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ta7g82h4cpjg4ib06g8v49dknv